share_log

EF Hutton Reiterates Buy on VolitionRX, Maintains $4.5 Price Target

Benzinga ·  Jan 3 02:34

EF Hutton analyst Tim Moore reiterates VolitionRX (AMEX:VNRX) with a Buy and maintains $4.5 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment